LSTA

0.89002.20%
JN

James Nisco

SVP of Finance and Treasury & Chief Accounting Officer

Mr. James Nisco serves as it's Senior VP of Finance and Treasury and Chief Accounting Officer at Lisata Therapeutics, Inc. (formerly known as Caladrius Biosciences, Inc.) since April 15, 2024 and served as its Vice President of Finance and Treasury from March 2021 to April 15, 2024 and. Mr. Nisco joined Caladrius Biosciences in 2012. As Vice President of Finance & Treasury, he was responsible for SEC reporting, financial reporting and accounting, treasury operations and financial planning and analysis. From February 2012 to August 2020, Mr. Nisco served as Senior Director of Treasury, Financial Planning and Analysis. Mr. Nisco oversees all finance activities for the Company while Caladrius conducts its search for a new chief financial officer. With over 25 years of experience in corporate finance, James has held various senior finance positions prior to Caladrius at OSI Pharmaceuticals, Inc., (acquired by Astellas) and Ciba Corporation (acquired by The BASF Group). James began his career at Ciba-Geigy (now Novartis Pharmaceuticals). Mr. Nisco holds an MBA in Financial Management from Pace University and a Bachelor of Science in Business Economics from the State University of New York, College at Oneonta.

Positions